How the KCNT1 channel affects different brain cells in childhood epilepsy
Cell Type-Specific Roles of the Na-Activated K Current in KCNT1-Related Epilepsy
Testing whether KCNT1 gene changes damage inhibitory brain cells and whether new KCNT1-blocking drugs can reduce seizures in children with KCNT1-related epilepsy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Polytechnic Inst and St Univ NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-11231737 on NIH RePORTER |
What this research studies
Researchers use mouse models carrying the same KCNT1 mutations found in affected children to find which brain cell types are harmed. They record electrical activity from inhibitory and excitatory neurons to see how KCNT1 changes alter cell firing. The team will apply newly developed KCNT1-selective inhibitors to measure channel currents in specific cell types and observe effects on brain activity. They will link cell-level defects to seizures or cortical hyperexcitability to guide targeted therapies.
Who could benefit from this research
Good fit: Children (and families) with epilepsy caused by KCNT1 gene variants would be the most relevant group to follow this work or join future KCNT1-targeted trials.
Not a fit: People with epilepsy caused by other genes or mechanisms are unlikely to receive direct benefit from therapies that specifically target KCNT1 channels.
Why it matters
Potential benefit: Could identify the vulnerable brain cell types and show that KCNT1 blockers reduce seizures, guiding new treatments for KCNT1-related childhood epilepsy.
How similar studies have performed: Previous lab work showed KCNT1 disease variants change channel activity in non-neuronal cells, but applying KCNT1-selective blockers to specific brain cell types and reducing seizures in animals or people is still largely untested.
Where this research is happening
Blacksburg, United States
- Virginia Polytechnic Inst and St Univ — Blacksburg, United States (Active)
Researchers
- Principal investigator: Weston, Matthew C — Virginia Polytechnic Inst and St Univ
- Study coordinator: Weston, Matthew C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.